A study to learn how safe and tolerable odronextamab and cemiplimab are in adult patients with B-cell malignancies
R1979-ONC-1504
Phase 1 other active
Quick answer
A study to learn how safe and tolerable odronextamab and cemiplimab are in adult patients with B-cell malignancies for B-Cell Non-Hodgkin’s Lymphoma (B-NHL) is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- B-Cell Non-Hodgkin’s Lymphoma (B-NHL)
- Phase
- Phase 1
- Modality
- other
- Status
- active